Hiberix should not be administered to subjects with known hypersensitivity to any component of the vaccine, or to subjects having shown signs of hypersensitivity after previous administration of Hib vaccines.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
